A new study reveals that dual-atom catalysts behave in a fundamentally different way than scientists previously thought, challenging a long-standing model used to predict catalytic performance.
The SUBITO trial, presented by Rianne L Seefat and colleagues in The Lancet Oncology,1 revisits the long-standing debate ...
Dissecting protective versus detrimental immune responses uncovers biomarkers and mechanisms that can inform the rational design and evaluation of live attenuated vaccines against African swine fever ...
Learn how to use the Relative Vigor Index (RVI) to measure trend strength and smooth price fluctuations in trading, with an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results